<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31409689</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01903-19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.01903-19</ELocationID><Abstract><AbstractText>Acute flaccid myelitis (AFM) has caused motor paralysis in &gt;560 children in the United States since 2014. The temporal association of enterovirus (EV) outbreaks with increases in AFM cases and reports of fever, respiratory, or gastrointestinal illness prior to AFM in &gt;90% of cases suggest a role for infectious agents. Cerebrospinal fluid (CSF) from 14 AFM and 5 non-AFM patients with central nervous system (CNS) diseases in 2018 were investigated by viral-capture high-throughput sequencing (VirCapSeq-VERT system). These CSF and serum samples, as well as multiple controls, were tested for antibodies to human EVs using peptide microarrays. EV RNA was confirmed in CSF from only 1 adult AFM case and 1 non-AFM case. In contrast, antibodies to EV peptides were present in CSF of 11 of 14 AFM patients (79%), significantly higher than controls, including non-AFM patients (1/5 [20%]), children with Kawasaki disease (0/10), and adults with non-AFM CNS diseases (2/11 [18%]) (<i>P</i> = 0.023, 0.0001, and 0.0028, respectively). Six of 14 CSF samples (43%) and 8 of 11 sera (73%) from AFM patients were immunoreactive to an EV-D68-specific peptide, whereas the three control groups were not immunoreactive in either CSF (0/5, 0/10, and 0/11; <i>P</i> = 0.008, 0.0003, and 0.035, respectively) or sera (0/2, 0/8, and 0/5; <i>P</i> = 0.139, 0.002, and 0.009, respectively).<b>IMPORTANCE</b> The presence in cerebrospinal fluid of antibodies to EV peptides at higher levels than non-AFM controls supports the plausibility of a link between EV infection and AFM that warrants further investigation and has the potential to lead to strategies for diagnosis and prevention of disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Mishra et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mishra</LastName><ForeName>Nischay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ng</LastName><ForeName>Terry Fei Fan</ForeName><Initials>TFF</Initials><Identifier Source="ORCID">0000-0002-4815-8697</Identifier><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marine</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Komal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakkar</LastName><ForeName>Riddhi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caciula</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Joel A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Jane C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Kiran T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Division of Critical Care and Hospitalist Neurology, Department of Neurology, Columbia Irving University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hetzler</LastName><ForeName>Kimbell L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Routh</LastName><ForeName>Janell A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konopka-Anstadt</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nix</LastName><ForeName>W Allan</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokarz</LastName><ForeName>Rafal</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briese</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Oberste</LastName><ForeName>M Steven</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lipkin</LastName><ForeName>W Ian</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA wil2001@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 NS105935</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI109761</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI138370</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="N">Central Nervous System Viral Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="N">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="N">Myelitis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="N">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040081" MajorTopicYN="N">Protein Array Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VirCapSeq-VERT</Keyword><Keyword MajorTopicYN="N">acute flaccid myelitis</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">enterovirus D-68</Keyword><Keyword MajorTopicYN="N">peptide array</Keyword><Keyword MajorTopicYN="N">serology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31409689</ArticleId><ArticleId IdType="pmc">PMC6692520</ArticleId><ArticleId IdType="doi">10.1128/mBio.01903-19</ArticleId><ArticleId IdType="pii">mBio.01903-19</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF, Wassilak S. 2019. Progress toward polio eradication&#x2014;worldwide, January 2017&#x2013;March 2019. MMWR Morb Mortal Wkly Rep 68:458&#x2013;462. doi:10.15585/mmwr.mm6820a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6820a3</ArticleId><ArticleId IdType="pmc">PMC6532951</ArticleId><ArticleId IdType="pubmed">31120868</ArticleId></ArticleIdList></Reference><Reference><Citation>Division of Viral Diseases, National Centers for Immunization and Respiratory Diseases, CDC, Division of Vector-Borne Diseases, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Children&#x2019;s Hospital Colorado, Council of State and Territorial Epidemiologists. 2015. Notes from the field: acute flaccid myelitis among persons aged &#x2264;21 years&#x2014;United States, August 1&#x2013;November 13, 2014. MMWR Morb Mortal Wkly Rep 63:1243&#x2013;1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646045</ArticleId><ArticleId IdType="pubmed">25577990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson GR, Bonkowsky JL, Doll E, Green M, Hedlund GL, Moore KR, Bale JF Jr.. 2016. Recognition and management of acute flaccid myelitis in children. Pediatr Neurol 55:17&#x2013;21. doi:10.1016/j.pediatrneurol.2015.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2015.10.007</ArticleId><ArticleId IdType="pubmed">26621554</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, Glaser C, Kambhampati A, Shioda K, Aliabadi N, Fischer M, Gregoricus N, Lanciotti R, Nix WA, Sakthivel SK, Schmid DS, Seward JF, Tong S, Oberste MS, Pallansch M, Feikin D. 2016. Acute flaccid myelitis in the United States, August&#x2013;December 2014: results of nationwide surveillance. Clin Infect Dis 63:737&#x2013;745. doi:10.1093/cid/ciw372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw372</ArticleId><ArticleId IdType="pmc">PMC5709818</ArticleId><ArticleId IdType="pubmed">27318332</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese T, Kapoor A, Mishra N, Jain K, Kumar A, Jabado OJ, Lipkin WI. 2015. Virome capture sequencing enables sensitive viral diagnosis and comprehensive virome analysis. mBio 6:e01491-15. doi:10.1128/mBio.01491-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01491-15</ArticleId><ArticleId IdType="pmc">PMC4611031</ArticleId><ArticleId IdType="pubmed">26396248</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N, Caciula A, Price A, Thakkar R, Ng J, Chauhan LV, Jain K, Che X, Espinosa DA, Montoya Cruz M, Balmaseda A, Sullivan EH, Patel JJ, Jarman RG, Rakeman JL, Egan CT, Reusken C, Koopmans MPG, Harris E, Tokarz R, Briese T, Lipkin WI. 2018. Diagnosis of Zika virus infection by peptide array and enzyme-linked immunosorbent assay. mBio 9:e00095-18. doi:10.1128/mBio.00095-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00095-18</ArticleId><ArticleId IdType="pmc">PMC5844993</ArticleId><ArticleId IdType="pubmed">29511073</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokarz R, Mishra N, Tagliafierro T, Sameroff S, Caciula A, Chauhan L, Patel J, Sullivan E, Gucwa A, Fallon B, Golightly M, Molins C, Schriefer M, Marques A, Briese T, Lipkin WI. 2018. A multiplex serologic platform for diagnosis of tick-borne diseases. Sci Rep 8:3158. doi:10.1038/s41598-018-21349-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21349-2</ArticleId><ArticleId IdType="pmc">PMC5816631</ArticleId><ArticleId IdType="pubmed">29453420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. 2006. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 44:2698&#x2013;2704. doi:10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovi T, Roivainen M. 1993. Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol 31:1083&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC262883</ArticleId><ArticleId IdType="pubmed">8388885</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, Van Leer-Buter C, Niesters HGM, Tyler KL, Abzug MJ, Dominguez SR. 2018. Enterovirus D68 and acute flaccid myelitis&#x2014;evaluating the evidence for causality. Lancet Infect Dis 18:e239&#x2013;e247. doi:10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Bian L, Gao F, Du R, Hu Y, Fu Y, Su Y, Wu X, Mao Q, Liang Z. 2019. A neonatal mouse model of enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis. Antiviral Res 161:108&#x2013;115. doi:10.1016/j.antiviral.2018.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.11.013</ArticleId><ArticleId IdType="pubmed">30503887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Yu G, Leser JS, Yagi S, Clarke P, Chiu CY, Tyler KL. 2017. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog 13:e1006199. doi:10.1371/journal.ppat.1006199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006199</ArticleId><ArticleId IdType="pmc">PMC5322875</ArticleId><ArticleId IdType="pubmed">28231269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Moore DD, Nix WA, Oberste MS, Weldon WC. 2015. Neutralization of enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products. J Clin Virol 69:172&#x2013;175. doi:10.1016/j.jcv.2015.06.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.06.086</ArticleId><ArticleId IdType="pmc">PMC6512324</ArticleId><ArticleId IdType="pubmed">26209401</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Fokine A, Meng G, Shin WH, Long F, Kuhn RJ, Kihara D, Rossmann MG. 2015. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347:71&#x2013;74. doi:10.1126/science.1261962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. 2019. Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak, Kansas City, Missouri, USA. Emerg Infect Dis 25:585&#x2013;588. doi:10.3201/eid2503.180960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2503.180960</ArticleId><ArticleId IdType="pmc">PMC6390745</ArticleId><ArticleId IdType="pubmed">30789123</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay SL, Lee AD, Lopez AS, Nix WA, Dooling KL, Keaton AA, Spence-Davizon E, Herlihy R, Clark TA, Hopkins SE, Pastula DM, Sejvar J, Oberste MS, Pallansch MA, Patel M, Routh JA. 2018. Increase in acute flaccid myelitis&#x2014;United States, 2018. MMWR Morb Mortal Wkly Rep 67:1273&#x2013;1275. doi:10.15585/mmwr.mm6745e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6745e1</ArticleId><ArticleId IdType="pmc">PMC6290805</ArticleId><ArticleId IdType="pubmed">30439867</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Penaranda S, Rogers SL, Henderson E, Nix WA. 2010. Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimens. J Clin Virol 49:73&#x2013;74. doi:10.1016/j.jcv.2010.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.06.022</ArticleId><ArticleId IdType="pubmed">20667767</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Maher K, Johansson ES, Niklasson B, Lindberg AM, Pallansch MA, Oberste MS. 2008. Detection of all known parechoviruses by real-time PCR. J Clin Microbiol 46:2519&#x2013;2524. doi:10.1128/JCM.00277-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00277-08</ArticleId><ArticleId IdType="pmc">PMC2519456</ArticleId><ArticleId IdType="pubmed">18524969</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JC, Glode MP. 2004. Kawasaki syndrome. Lancet 364:533&#x2013;544. doi:10.1016/S0140-6736(04)16814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16814-1</ArticleId><ArticleId IdType="pubmed">15302199</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JC. 2019. New perspectives on Kawasaki disease. Arch Dis Child 104:616. doi:10.1136/archdischild-2018-316322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2018-316322</ArticleId><ArticleId IdType="pubmed">30700406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumede N, Jorba J, Deshpande J, Pallansch M, Yogolelo R, Muyembe-Tamfum JJ, Kew O, Venter M, Burns CC. 2014. Phylogeny of imported and reestablished wild polioviruses in the Democratic Republic of the Congo from 2006 to 2011. J Infect Dis 210(Suppl 1):S361&#x2013;S367. doi:10.1093/infdis/jiu375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu375</ArticleId><ArticleId IdType="pmc">PMC4303083</ArticleId><ArticleId IdType="pubmed">25316856</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza TML, Vieira YR, Delatorre E, Barbosa-Lima G, Luiz RLF, Vizzoni A, Jain K, Miranda MM, Bhuva N, Gogarten JF, Ng J, Thakkar R, Calheiros AS, Monteiro APT, Bozza PT, Bozza FA, Tschoeke DA, Leomil L, Mendonca MCL, Rodrigues C, Torres MC, Filippis AMB, Nogueira RMR, Thompson FL, Lemos C, Durovni B, Cerbino-Neto J, Morel CM, Lipkin WI, Mishra N. 2019. Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection. Sci Rep 9:2760. doi:10.1038/s41598-019-39406-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39406-9</ArticleId><ArticleId IdType="pmc">PMC6391440</ArticleId><ArticleId IdType="pubmed">30809003</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Okamoto M, Nakakita S, Suzuki A, Saito M, Tamaki R, Lupisan S, Roy CN, Hiramatsu H, Sugawara KE, Mizuta K, Matsuzaki Y, Suzuki Y, Oshitani H. 2014. Antigenic and receptor binding properties of enterovirus 68. J Virol 88:2374&#x2013;2384. doi:10.1128/JVI.03070-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03070-13</ArticleId><ArticleId IdType="pmc">PMC3958110</ArticleId><ArticleId IdType="pubmed">24371050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>